128 related articles for article (PubMed ID: 23302165)
1. [Expression of metallothionein 2 in middle ear cholesteatoma and its correlation with interleukin 1α and interleukin 6].
Liu Y; Yu LL; Han J; Cheng JN; Yang DZ
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Oct; 47(10):831-5. PubMed ID: 23302165
[TBL] [Abstract][Full Text] [Related]
2. [Expression of hypoxia-inducible factor-1alpha in middle ear cholesteatoma].
Liu Y; Cui Y; Yu L; Zhang P
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Jan; 19(1):4-6. PubMed ID: 15830692
[TBL] [Abstract][Full Text] [Related]
3. [Expression and significance of HIF-1alpha and iNOS in human middle ear cholesteatoma epithelium].
Zhang E; Gong S
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 May; 21(10):463-5. PubMed ID: 17650819
[TBL] [Abstract][Full Text] [Related]
4. Expression of tumor necrosis factor-α, interleukin-1α, interleukin-6 and interleukin-10 in chronic otitis media with bone osteolysis.
Kuczkowski J; Sakowicz-Burkiewicz M; Iżycka-Świeszewska E; Mikaszewski B; Pawełczyk T
ORL J Otorhinolaryngol Relat Spec; 2011; 73(2):93-9. PubMed ID: 21311206
[TBL] [Abstract][Full Text] [Related]
5. [The expression of matrix metalloproteinase-1 and interleukin-1-alpha messenger ribonucleic acid in human middle ear cholesteatoma].
Liu J; Lin G; Huang J; Jiang Z
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2002 Feb; 37(1):30-3. PubMed ID: 12768791
[TBL] [Abstract][Full Text] [Related]
6. Roles of cytokines and cell cycle regulating substances in proliferation of cholesteatoma epithelium.
Tanaka Y; Kojima H; Miyazaki H; Koga T; Moriyama H
Laryngoscope; 1999 Jul; 109(7 Pt 1):1102-7. PubMed ID: 10401849
[TBL] [Abstract][Full Text] [Related]
7. Hepatic metallothionein in patients with chronic hepatitis C: relationship with severity of liver disease and response to treatment.
Carrera G; Paternain JL; Carrere N; Folch J; Courtade-Saïdi M; Orfila C; Vinel JP; Alric L; Pipy B
Am J Gastroenterol; 2003 May; 98(5):1142-9. PubMed ID: 12809840
[TBL] [Abstract][Full Text] [Related]
8. Quantitative analysis of interleukin-1-alpha gene expression in middle ear cholesteatoma.
Bujía J; Kim C; Boyle D; Hammer C; Firestein G; Kastenbauer E
Laryngoscope; 1996 Feb; 106(2 Pt 1):217-20. PubMed ID: 8583857
[TBL] [Abstract][Full Text] [Related]
9. Different production of interleukin-1alpha, interleukin-1beta and interleukin-8 from cholesteatomatous and normal epithelium.
Chung JW; Yoon TH
Acta Otolaryngol; 1998 Jun; 118(3):386-91. PubMed ID: 9655214
[TBL] [Abstract][Full Text] [Related]
10. [The expression and significance of human beta-defensin 2 in middle ear cholesteatoma epithelium].
Ren X; Cui P; Chen W; Xu M
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Apr; 19(7):313-4. PubMed ID: 16001900
[TBL] [Abstract][Full Text] [Related]
11. [Activation of nuclear factor-kappaB and aberrant gene expression of interleukin 6 in middle ear cholesteatoma].
Xu Y; Tao ZZ; Hua QQ; Wang XC; Xiao BK; Chen SM
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2009 Mar; 44(3):192-6. PubMed ID: 19558856
[TBL] [Abstract][Full Text] [Related]
12. The effect of BMP-2, BMP-4 and BMP-6 on bone destruction of cholesteatoma presence.
Oger M; Alpay HC; Orhan I; Onalan EE; Yanilmaz M; Sapmaz E
Am J Otolaryngol; 2013; 34(6):652-7. PubMed ID: 23927997
[TBL] [Abstract][Full Text] [Related]
13. Possible role of interleukin 1 alpha and interleukin 1 beta in the pathogenesis of cholesteatoma of the middle ear.
Schilling V; Negri B; Bujía J; Schulz P; Kastenbauer E
Am J Otol; 1992 Jul; 13(4):350-5. PubMed ID: 1384343
[TBL] [Abstract][Full Text] [Related]
14. Association between human beta defensin expression and cholesteatoma formation.
Meyer JE; Schwaab M; Beier UH; Görögh T; Buchelt T; Frese K; Maune S
Auris Nasus Larynx; 2006 Jun; 33(2):159-65. PubMed ID: 16431059
[TBL] [Abstract][Full Text] [Related]
15. Cell cycle inhibitory protein p27 in human middle ear cholesteatoma.
Kuczkowski J; Bakowska A; Pawelczyk T; Narozny W; Mikaszewski B
ORL J Otorhinolaryngol Relat Spec; 2006; 68(5):296-301. PubMed ID: 16825801
[TBL] [Abstract][Full Text] [Related]
16. [Expression of transforming growth factor-beta1 and c-fos and p27 in human middle ear cholesteatoma].
Jiang CW; Zhan HM; Wang WH; Zhang L; Jin SZ; Yang YB; Zhang ZJ
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Apr; 39(4):211-5. PubMed ID: 15283280
[TBL] [Abstract][Full Text] [Related]
17. [The expression of Ras protein in human middle ear cholesteatoma].
Xu Y; Jin K; Dong W
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1999 Apr; 34(2):74-6. PubMed ID: 12764851
[TBL] [Abstract][Full Text] [Related]
18. Activation of the IL-6/JAK/STAT3 signaling pathway in human middle ear cholesteatoma epithelium.
Liu W; Xie S; Chen X; Rao X; Ren H; Hu B; Yin T; Xiang Y; Ren J
Int J Clin Exp Pathol; 2014; 7(2):709-15. PubMed ID: 24551293
[TBL] [Abstract][Full Text] [Related]
19. Expressions of caspase-14 in human middle ear cholesteatoma.
Jung MH; Lee JH; Cho JG; Jung HH; Hwang SJ; Chae SW
Laryngoscope; 2008 Jun; 118(6):1047-50. PubMed ID: 18520823
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of peroxidase proliferator-activated receptor gamma in cholesteatoma.
Hwang SJ; Kang HJ; Song JJ; Kang JS; Woo JS; Chae SW; Lee HM
Laryngoscope; 2006 Jan; 116(1):58-61. PubMed ID: 16481810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
